Shares of agilon health, inc. (AGL) have displayed volatile yet predominantly bullish price action over the last 30 days and quarter. Following a 1-for-25 reverse stock split in late March, the stock surged over 130% in recent weeks on elevated volume, breaking above key resistance levels amid post-earnings momentum. A sharp rally on April 16 pushed prices to $30.94, but subsequent selling has led to a correction, with the price now hovering near $24.13 after testing intraday lows. This pullback follows an overbought phase, forming a potential consolidation range between $24 and $28, characteristic of profit-taking after strong gains.
The broader trend for AGL remains upward, supported by a golden cross between the 50-day and 200-day moving averages earlier in the year. Year-to-date gains exceed 40%, reflecting sustained buying interest. However, the short-term trend has shifted to corrective, as price action has dipped below shorter moving averages. Traders are watching for continuation above recent highs or a deeper retracement toward quarterly lows.
Classic pivot points highlight immediate support at $23.60 (S1), $23.17 (S2), and $22.48 (S3), aligning with prior consolidation zones. The central pivot stands at $24.29, where recent price action has stabilized. Resistance begins at $24.72 (R1), followed by $25.41 (R2) and $25.84 (R3), coinciding with prior breakout levels and shorter moving averages. A hold above $24 could signal renewed upside, while a breach below $23.60 may target deeper supports near the 100-day moving average.
Shorter-term simple and exponential moving averages (5-day at 25.65, 10-day at 27.10, 20-day at 28.58, 50-day at 25.63) all indicate sell signals, as the price trades below these levels during the current pullback. In contrast, the 100-day (20.09 simple) and 200-day (15.83 simple) moving averages provide buy signals, underscoring the longer-term bullish structure. Overall, moving averages summarize to a sell, reflecting near-term weakness against the prevailing uptrend.
Momentum has cooled significantly. The RSI(14) reading of 38.773 suggests oversold territory, with Stochastic(9,6) at 36.284 and Williams %R at -87.521 confirming exhaustion among sellers. MACD(12,26) at -0.13 generates a sell signal, supported by a bearish ADX(14) of 27.318 and CCI(14) at -148.94. These indicators point to a potential bounce if support holds, but sustained weakness could extend the correction.
Volume spiked notably during the April rally, confirming the breakout with above-average participation. Recent sessions show elevated turnover amid the pullback, indicating active trader interest. Declining volume on the downside could signal fading selling pressure, setting up for stabilization.
Tickeron’s AI Daily Buy/Sell Signals leverage artificial intelligence to scrutinize vast arrays of market data, technical indicators, and recurring price patterns, delivering actionable buy or sell signals for stocks like AGL. Grounded in trend recognition, historical precedents, and quantitative models, these signals help traders pinpoint potential entry/exit points, validate trend strength, and refine decision-making processes. Widely utilized by retail and professional traders alike, they offer an objective layer to technical analysis. Explore the latest signals to enhance your trading strategy.
Traders are focused on whether AGL holds pivot support near $24, which could pave the way for a retest of $25.41 resistance and resumption of the uptrend. A breakdown below $23.60 might accelerate toward $22.48 or the 100-day moving average. Monitor RSI for oversold relief and MACD for crossover signals, alongside volume for confirmation of direction. The interplay of shorter-term weakness and longer-term bullishness keeps the chart poised for volatility.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
A.I.dvisor tells us that AGL and LFST have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AGL and LFST's prices will move in lockstep.
| Ticker / NAME | Correlation To AGL | 1D Price Change % | ||
|---|---|---|---|---|
| AGL | 100% | -2.80% | ||
| LFST - AGL | 32% Poorly correlated | -1.28% | ||
| CCRN - AGL | 30% Poorly correlated | -0.15% | ||
| TOI - AGL | 27% Poorly correlated | +3.51% | ||
| BKD - AGL | 26% Poorly correlated | +3.79% | ||
| TALK - AGL | 25% Poorly correlated | N/A | ||
More | ||||
| Ticker / NAME | Correlation To AGL | 1D Price Change % |
|---|---|---|
| AGL | 100% | -2.80% |
| Hospital/Nursing Management industry (51 stocks) | 17% Poorly correlated | +0.11% |